Yu Kato

7.7k total citations · 1 hit paper
14 papers, 1.2k citations indexed

About

Yu Kato is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Yu Kato has authored 14 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Infectious Diseases. Recurrent topics in Yu Kato's work include T-cell and B-cell Immunology (6 papers), Immunotherapy and Immune Responses (5 papers) and Immune Cell Function and Interaction (4 papers). Yu Kato is often cited by papers focused on T-cell and B-cell Immunology (6 papers), Immunotherapy and Immune Responses (5 papers) and Immune Cell Function and Interaction (4 papers). Yu Kato collaborates with scholars based in United States, Australia and Japan. Yu Kato's co-authors include William R. Heath, Irina Caminschi, Scott N. Mueller, Mireille H. Lahoud, Thiago M. Steiner, Shusaku Mizukami, Gayle M. Davey, Heiichiro Udono, Chiaki Kajiwara and Ikuo Ishige and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The EMBO Journal.

In The Last Decade

Yu Kato

14 papers receiving 1.2k citations

Hit Papers

BMK1/ERK5 regulates serum-induced early gene expression t... 1997 2026 2006 2016 1997 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Kato United States 10 721 522 164 114 101 14 1.2k
Svend Kjær United Kingdom 16 501 0.7× 507 1.0× 146 0.9× 186 1.6× 84 0.8× 27 1.1k
Mietske Wijers Netherlands 14 486 0.7× 530 1.0× 131 0.8× 138 1.2× 60 0.6× 17 1.1k
Béatrice Kunz Switzerland 17 674 0.9× 366 0.7× 123 0.8× 254 2.2× 72 0.7× 26 1.2k
Nicholas M. Stamatos United States 19 658 0.9× 385 0.7× 98 0.6× 126 1.1× 146 1.4× 23 1.1k
Marie-José Bijlmakers United Kingdom 17 661 0.9× 563 1.1× 158 1.0× 206 1.8× 44 0.4× 21 1.3k
Octavio Miguel Rivero-Lezcano Spain 15 496 0.7× 290 0.6× 142 0.9× 228 2.0× 153 1.5× 35 1.0k
Klaus Schwamborn France 14 751 1.0× 190 0.4× 141 0.9× 113 1.0× 60 0.6× 20 1.0k
Martine Humbert France 12 457 0.6× 598 1.1× 234 1.4× 102 0.9× 49 0.5× 15 1.2k
Qi‐Hong Sun China 18 539 0.7× 269 0.5× 136 0.8× 189 1.7× 33 0.3× 40 1.6k
Peter Gee Japan 18 961 1.3× 269 0.5× 230 1.4× 49 0.4× 102 1.0× 27 1.4k

Countries citing papers authored by Yu Kato

Since Specialization
Citations

This map shows the geographic impact of Yu Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Kato more than expected).

Fields of papers citing papers by Yu Kato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Kato. The network helps show where Yu Kato may publish in the future.

Co-authorship network of co-authors of Yu Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Kato. A scholar is included among the top collaborators of Yu Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Kato. Yu Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kato, Yu, Michael Pokrass, Jinkil Jeong, et al.. (2024). Nonclinical characterization of ICVB-1042 as a selective oncolytic adenovirus for solid tumor treatment. Communications Biology. 7(1). 1132–1132. 3 indexed citations
2.
Pecetta, Simone, Sven Kratochvil, Yu Kato, Kumaran Vadivelu, & Rino Rappuoli. (2022). Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines. Pharmacological Reviews. 74(1). 313–339. 7 indexed citations
3.
Boland, Brigid S., Benjamin Goodwin, Zeli Zhang, et al.. (2022). Preserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating Therapies. Clinical and Translational Gastroenterology. 13(4). e00484–e00484. 9 indexed citations
4.
Kato, Yu, Nathaniel I. Bloom, Peifang Sun, et al.. (2022). Memory B-Cell Development After Asymptomatic or Mild Symptomatic SARS-CoV-2 Infection. The Journal of Infectious Diseases. 227(1). 18–22. 6 indexed citations
5.
Evrard, Maximilien, Erica Wynne-Jones, Changwei Peng, et al.. (2021). Sphingosine 1-phosphate receptor 5 (S1PR5) regulates the peripheral retention of tissue-resident lymphocytes. The Journal of Experimental Medicine. 219(1). 64 indexed citations
6.
Kato, Yu, Robert Abbott, Sonya Haupt, et al.. (2020). Multifaceted Effects of Antigen Valency on B Cell Response Composition and Differentiation In Vivo. Immunity. 53(3). 548–563.e8. 135 indexed citations
7.
Nabekura, Tomohiro, Tatsuya Kawasaki, Yu Kato, et al.. (2020). Citrus auraptene induces drug efflux transporter P-glycoprotein expression in human intestinal cells. Food & Function. 11(6). 5017–5023. 11 indexed citations
8.
Heath, William R., Yu Kato, Thiago M. Steiner, & Irina Caminschi. (2019). Antigen presentation by dendritic cells for B cell activation. Current Opinion in Immunology. 58. 44–52. 63 indexed citations
9.
Harpur, Christopher M., Yu Kato, Sanda Stankovic, et al.. (2018). Classical Type 1 Dendritic Cells Dominate Priming of Th1 Responses to Herpes Simplex Virus Type 1 Skin Infection. The Journal of Immunology. 202(3). 653–663. 27 indexed citations
10.
Kato, Yu, Ali Zaid, Gayle M. Davey, et al.. (2015). Targeting Antigen to Clec9A Primes Follicular Th Cell Memory Responses Capable of Robust Recall. The Journal of Immunology. 195(3). 1006–1014. 57 indexed citations
11.
Kato, Yu, Chiaki Kajiwara, Ikuo Ishige, et al.. (2012). HSP70 and HSP90 Differentially Regulate Translocation of Extracellular Antigen to the Cytosol for Cross-Presentation. Autoimmune Diseases. 2012. 1–10. 21 indexed citations
12.
Imai, Takashi, Yu Kato, Chiaki Kajiwara, et al.. (2011). Heat shock protein 90 (HSP90) contributes to cytosolic translocation of extracellular antigen for cross-presentation by dendritic cells. Proceedings of the National Academy of Sciences. 108(39). 16363–16368. 123 indexed citations
13.
Lahoud, Mireille H., Fatma Ahmet, Susie Kitsoulis, et al.. (2011). Targeting Antigen to Mouse Dendritic Cells via Clec9A Induces Potent CD4 T Cell Responses Biased toward a Follicular Helper Phenotype. The Journal of Immunology. 187(2). 842–850. 177 indexed citations
14.
Kato, Yu. (1997). BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. The EMBO Journal. 16(23). 7054–7066. 511 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026